| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.144 | 63.181 | 65.360 | 65.431 | 65.774 | 77.799 | 75.549 | 77.562 | 77.714 | 75.720 |
| Total Income - EUR | 64.144 | 63.181 | 65.360 | 65.431 | 65.774 | 77.800 | 75.556 | 77.562 | 77.715 | 75.720 |
| Total Expenses - EUR | 74.528 | 73.728 | 74.660 | 75.245 | 74.289 | 84.515 | 81.216 | 83.664 | 84.972 | 85.757 |
| Gross Profit/Loss - EUR | -10.383 | -10.546 | -9.300 | -9.814 | -8.515 | -6.715 | -5.660 | -6.102 | -7.257 | -10.037 |
| Net Profit/Loss - EUR | -10.383 | -11.178 | -9.953 | -10.467 | -9.176 | -7.246 | -6.382 | -6.879 | -7.257 | -10.037 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Viofarm Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.421 | 552 | 40 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 19.649 | 14.839 | 17.122 | 17.844 | 18.741 | 23.353 | 24.063 | 27.520 | 28.879 | 24.173 |
| Inventories | 8.764 | 7.781 | 8.083 | 6.482 | 9.821 | 12.977 | 14.120 | 16.412 | 18.081 | 16.713 |
| Receivables | 8.090 | 2.867 | 8.729 | 9.712 | 8.238 | 9.675 | 9.421 | 10.475 | 9.270 | 7.349 |
| Cash | 2.796 | 4.191 | 309 | 1.650 | 682 | 702 | 522 | 633 | 1.528 | 111 |
| Shareholders Funds | -20.481 | -31.450 | -40.871 | -50.588 | -58.785 | -64.917 | -69.859 | -76.853 | -83.877 | -93.446 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 41.551 | 46.841 | 58.033 | 68.438 | 77.526 | 88.368 | 94.126 | 104.612 | 113.018 | 117.883 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Viofarm Impex Srl